Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era

RATIONALE & OBJECTIVE: Since the change in erythropoiesis-stimulating agent (ESA) labeling and bundling of dialysis services in the United States, few studies have addressed the clinical importance of ESA hyporesponsiveness and none have considered health care resource use in this population. We...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Kidney Med
Главные авторы: Cizman, Borut, Smith, Helen T., Camejo, Rodrigo Refoios, Casillas, Linda, Dhillon, Harjeet, Mu, Fan, Wu, Eric, Xie, Jipan, Zuckerman, Peter, Coyne, Daniel
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568064/
https://ncbi.nlm.nih.gov/pubmed/33089137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2020.06.008
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы